Citadel Advisors’s BlueLinx BXC Stock Holding History
Bought
Maintained
Sold
Other funds holding BXC
GJL
JCP
VCM
PAIM
RRAM
Citadel Advisors's BXC Position: Q1 2026 in Review
Citadel Advisors increased its BlueLinx (BXC) stake by 54% in Q1 2026, buying an estimated $629K and bringing the position to 27,395 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #6734.
Citadel Advisors first reported a position in BXC in Q4 2013 and has held it in 30 quarters since. The position peaked at $8.18M in Q4 2023. 145 funds tracked by Wall St. Rank hold BXC as of Q1 2026.
- Citadel Advisors held 27,395 shares of BlueLinx worth $1.48M as of Q1 2026.
- Citadel Advisors bought 9,580 BlueLinx shares in Q1 2026, an estimated $629K.
- BlueLinx made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6734 holding.
- Citadel Advisors first reported a position in BlueLinx in Q4 2013 and has held it in 30 quarters since.
- Citadel Advisors's BlueLinx position peaked at $8.18M in Q4 2023.
- 145 funds tracked by Wall St. Rank held BlueLinx as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.